/PRNewswire/ Yi Zhang and shareholders representing over 59.2% of the outstanding shares of YS Biopharma Co., Ltd. (the "Company" or "YS") (NASDAQ: YS) (the.
/PRNewswire/ Shareholders of YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma"), a global biopharmaceutical company dedicated to discovering, developing,.
Shareholders of YS Biopharma Announce an Extraordinary General Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
GAITHERSBURG, Md., Dec. 20, 2023 /PRNewswire/ YS Biopharma Co., Ltd. , a global biopharmaceutical company, today announced that upon the receipt of a notice from the Chairperson of the Board of.